Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 2Phase 1/2 1

Status

Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 523Leukemia, Myeloid, Acute 500Neoplasms 382Carcinoma, Non-Small-Cell Lung 381Pancreatic Neoplasms 329Precursor Cell Lymphoblastic Leukemia-Lymphoma 319Multiple Myeloma 312Glioblastoma 312Melanoma 310Prostatic Neoplasms 293Leukemia 289Neoplasm Metastasis 285Brain Neoplasms 277Lymphoma 271Lung Neoplasms 270Recurrence 267Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 242Leukemia, Lymphocytic, Chronic, B-Cell 231Glioma 210Myelodysplastic Syndromes 208Lymphoma, Large B-Cell, Diffuse 187Carcinoma, Hepatocellular 173Lymphoma, Follicular 168Head and Neck Neoplasms 162Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Interventions

codrituzumab 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Simpson-Golabi-Behmel syndrome × Clear all
NCT07513194 2026-04-07

GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)

Baylor College of Medicine

Phase 1 Not yet recruiting
21 enrolled

Simpson-Golabi-Behmel syndrome, Rhabdoid Tumor

NCT04928677 2026-02-17

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
50 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Recurrence, Hepatoblastoma

NCT03198546 2024-06-25

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

Second Affiliated Hospital of Guangzhou Medical University

Phase 1 Recruiting
30 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Carcinoma, Hepatocellular

NCT04121273 2021-03-03

GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 1 Unknown
20 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡